Trial Profile
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolaemic Hyponatraemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Aug 2016
Price :
$35
*
At a glance
- Drugs Lixivaptan (Primary)
- Indications Hyponatraemia
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Cardiokine
- 12 Aug 2014 New trial record
- 24 Nov 2010
- 06 Jul 2009